TOMASH
5 years ago
BBA - our branch
Brooklyn
2621 Atlantic Avenue
Brooklyn, NY 11207
https://www.google.cz/maps/place/2621+Atlantic+Ave,+Brooklyn,+NY+11207,+Spojen%C3%A9+st%C3%A1ty+americk%C3%A9/@40.6757588,-73.8976572,3a,50.7y,346.1h,92.15t/data=!3m6!1e1!3m4!1s8oTUjjLuLjBmpv-HuueayA!2e0!7i16384!8i8192!4m5!3m4!1s0x89c25c4e549fc18b:0x5976832bb779c0c2!8m2!3d40.6759265!4d-73.8976659
TOMASH
5 years ago
BBAL - SHAREHOLDERS
I own 200,000 shares that is approximately 0,45 % Company O/S
Outstanding Shares 43,636,716
Restricted 14,260,040
Unrestricted 29,376,676
I plan tu buy another 300,000 shares.
Someone else will be added ???
HDOGTX
13 years ago
PROXYVOTE.COM
You elected to receive shareholder communications and submit voting
instructions via the Internet. This e-mail notification contains
information specific to your holding in the security identified below.
Please read the instructions carefully before proceeding.
Important Notice Regarding the Availability of Proxy Materials
for the Shareholder Meeting
2011 NEW YORK HEALTH CARE, INC. Special Meeting of Stockholders
MEETING DATE: July 15, 2011
For Holders as of: May 26, 2011
CUSIP NUMBER: 649487204
ACCOUNT NUMBER: *****0467
CONTROL NUMBER: 822710692401
You can enter your voting instructions and view the shareholder material
at the following Internet site:
http://www.proxyvote.com/0822710692401
For our secure site:
https://www.proxyvote.com/0822710692401
Note: If your E-mail software supports it, you can simply click on the
above link.
Internet voting is accepted up to 11:59 p.m. (ET) the day before the
meeting/cut off date.
To view the documents below, you may need the Adobe Acrobat Reader. To
download the Adobe Acrobat Reader, click the URL address below:
http://www.adobe.com/products/acrobat/readstep2.html
The relevant supporting documentations can also be found at the
following Internet site(s):
Proxy Statement
https://materials.proxyvote.com/Approved/649487/20110526/NPS_95271.PDF
Shareholder Info
https://materials.proxyvote.com/Approved/649487/20110526/OTHER_95244.PDF
Shareholder Info
https://materials.proxyvote.com/Approved/649487/20110526/OTHER_95243.PDF
Financial Statement
https://materials.proxyvote.com/Approved/649487/20110526/OTHER_95242.PDF
If you would like to cancel your enrollment, or change your e-mail
address please contact your Client Services representative.
There are no charges for this electronic proxy delivery service. There
may be costs associated with electronic access, such as usage charges
from Internet access providers and telephone companies, which must be
borne by the stockholder.
If you have questions, please do not reply to this e-mail. Instead,
send an e-mail from the link on your secure trading site (for security
reasons, we cannot provide account information via e-mail unless your
e-mail is sent from our secure Web site). You may also call a Client
Services representative.
TD Ameritrade, Division of TD Ameritrade, Inc., member FINRA/SIPC/NFA.
TD Ameritrade is a trademark jointly owned by TD Ameritrade IP Company,
Inc. and Toronto-Dominion Bank. Copyright 2011 TD Ameritrade IP Company,
Inc. All rights reserved. Used with permission.
Distributed by TD AMERITRADE Clearing, Inc. 1005 North Ameritrade Place,
Bellevue, NE 68005
Helter Skelter
13 years ago
35,020,000 shares of common stock, $0.0001 par value, issued and outstanding as of May 9, 2011.
For ELGO. I think they have to issue shares to purchase those BioBalance subsidiaries...so no telling what that, the shares, may eventually turn into for BBAL (NYHC)...
Helter Skelter
13 years ago
Street Soldier ($ sign was playing havoc with the post), looking at ELGO's (Enterologics, Inc.) last 10-Q...they don't have any money. They are a development stage company. This would indicate to me that the agreement to purchase the BioBalance subsidiaries, from New Yok Health Care, Inc., will have to be done with shares.
Right now ELGO shares are listed @ $.27 with volume, today, of 17,880.
Hmmm...this is interesting (from ELGO's last 10-Q):
Item 2. Unregistered Sale of Securities and Use of Proceeds
In February 2011, we issued Surge Partners, Ltd. 500,000 shares of common stock in consideration for Surge agreeing to lend the Company loans up to an aggregate of $50,000. The shares were valued at $25,000 ($.05 per share). Irv Bader, the father of Lisa Grossman, is President of Surge Partners, The issuance was made in reliance upon an exemption from registration provided under Section 4(2) of the Securities Act of 1933, as amended.
Who is Lisa Grossman married to? Any relation to this fellow?
Post from the Enterologics ihub board:
anivad21 Share Monday, June 06, 2011 6:31:56 PM
Re: None Post # of 225
From: Yitz Grossman
Thursday, June 2, 2011 1:40 PM
Thank you for your mail and interest in Enterologics. And of course, we welcome you as a shareholder. Might we ask that you follow recent news releases and one planned for next week. I believe next weekβs release will clarify some of you questions. If not, kindly reach out to us again and Iβll call you with better answers.
Just wanted everyone to know things are coming this week.
---[]---
You'll remember from my previous post that Yitz Grossman owns/owned 33 1/3% of BioBalance subsidiaries...Yitz, in the above post/e-mail suggests news to be coming...this week...sorry...which was last week's news, I believe...
Hold and ponder!
So, what role, exactly, does Yitz play with Enterologics?
lol...enough DD from me, I'm busy with other mysteries, lol...
Helter Skelter
13 years ago
Right. There are 3 companies involved in this...transaction. New York Health Care, Inc., The BioBalance Corporation and BioBalance, LLC. Both BioBalance companies are Delaware corporations and NYHC is a New York corporation.
Enterologics (ELGO.OB) is buying the shares of The BioBalance Corporation and it's subsidiary, BioBalance, LLC, neither of which are publicly traded.
You are buying BBAL publicly traded shares which are the shares of NYHC (New York Health Care, Inc.). However, not all is lost if you thought you were buying something else. For one (1) BioBalance was valued @ $628,056. "As reported in the Companyβs Form 10-K for the year ended December 31, 2007, the net carrying value of the intellectual property of BioBalance after recording impairment losses was $628,056." and two (2) BBAL (NYHC) was on pace, in 2008, for yearly revenues of ~$50M and NET PROFITS of ~$1M-$3M which was/is $.03-$.09 earnings per share. If you multiply the EPS by a conservative PE ratio of 10 then BBAL (NYHC) could be valued @ $.30-$.90 per share! Then add the one time GAIN from sale of assets (BioBalance subsidiaries) of $.019 ($628,056 / 33,536,767 BBAL shares) to the price per share, prior to sale, and...who knows WHAT you got? lol...
You need to send correspondence to (or find the telephone number of):
New York Health Care, Inc.
1850 McDonald Avenue
Brooklyn, New York 11223
Attention: Mr. Murry Englard, Chief Executive Officer
with a copy to (his attorney at last filing):
Cohen Tauber Spievack & Wagner P.C.
420 Lexington Avenue
Suite 2400
New York, New York 10170
Attention: Adam Stein, Esq.
Yitz Grossman owns the other 33 1/3% of The BioBalance Corporation worth another $314,028. The PR didn't say whether these shares were also being bought but I imagine they are (or Grossman is coming along, to Enterologics, in some other capacity, maybe still 1/3 owner of BioBalance). A good question to ask the CEO of Enterologics, Inc., in my opinion.
Notice that BBAL's revenues grew almost 20%, Q over Q, from 2007 to 2008 and that Net Income went from a loss of $68,150 to a gain of $1,039,434:
Unfortunately, BBAL's (NYHC) balance sheet doesn't look all that good and may explain the drop in BBAL's price per share over the years:
As you can see from the balance sheet, BBAL (NYHC) owes more in liabilities than they own in assets. However, it's "only" an imbalance of ~$2.5M and they will likely receive ~$650,000 (give or take) from Enterologics that can go towards correcting the imbalance (paying off debt, whoever HRA is). Remember, though, that this information is dated by about 2 1/2 years. Call the CEO of BBAL, Murry Englard, and demand information. Not only with this transaction but with BBAL overall. Like...what are projected revenues for 2011? Will there be a profit (net income) for 2011? What happened after 2008, Q2, when they made ONE MILLION DOLLARS in profit? How much debt is left? Why is the trading illiquid (prior to this last PR)? What is the current OS? Did you sell any shares on this PR? lol...etcetera, etcetera...
Most of this data was derived from the last 10-Q filed on 11/14/2008 by New York Health Care, Inc. (BBAL). It is your mission, should you accept, to take this data and turn it into information, lol...
GLTA and good day.